An 80-year-old man was found to have a 1.4 cm lesion on right side of the lower lobe central parenchymal lung nodule on chest computed tomogram (CT) while undergoing evaluation for a cough [ Figure 1a and b]. The lesion was metabolically active on positive emission tomography without any evidence to suggest involvement of mediastinal/hilar nodes or distant metastasis. Flexible bronchoscopy with transbronchial biopsies confi rmed this lesion to be lung adenocarcinoma. The patient's comorbidities precluded surgical resection, and he was scheduled to have stereotactic body radiation therapy (SBRT). Given the central location of the nodule and its close proximity to the esophageal wall, fiducial markers placement inside the tumor was recommended. Convex probe endobronchial ultrasound (CP-EBUS) was used to place three fi ducial gold markers (0.35 mm × 5 mm, Visicoil, IBA) using a 22 Gauge EBUS needle (Olympus, NA-201SX-4022). The fi ducials were loaded into the EBUS needle distally (front-load), and bone wax was applied to secure the fi ducials in place [ Figure 1c In patients with multiple comorbidities that preclude surgery, alternative therapy such as SBRT is considered. Fiducial markers placement for lung cancers is commonly performed to guide SBRT or surgical resection. Percutaneous CT-guided fiducial placement is associated with pneumothorax rate up to 48%. [1] Since advanced bronchoscopic techniques provide improved diagnostic accuracy and fewer complications over conventional bronchoscopy, they are now more commonly used for fiducial markers placement to guide radiation therapy. Both radial probe EBUS and electromagnetic navigation have been used for implanting of fi ducial markers. [2] These devices may be used as markers to guide radiation therapy. The complication rate such as migration and pneumothorax is, usually, low. [3] In one group, 90% of the markers remained in place during the time of radiosurgery. [4] CP-EBUS is widely used for the diagnosis and mediastinal staging of lung cancer. CP-EBUS has been also used to guide fiducial markers placement in the peribronchial and mediastinal lymph nodes. [5] CP-EBUS can be utilized for diagnosis of central parenchymal lung nodules and masses, along with simultaneous mediastinal staging. In these cases, fiducial markers placement can be performed in the same setting using CP-EBUS as no complications have been reported. [5, 6] Convex probe endobronchial ultrasound placement of fi ducial markers is a safe and useful procedure to guide stereotactic radiosurgery for centrally located lung cancers. 
